MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Characteristics of the amyloid beta networks in Parkinson’s disease patients: a PPMI study

    A. Mihascu, M. Valli, M. Diez-Cirarda, Y. Koshimori, J. Kim, A. Strafella (Toronto, Canada)

    Objective: The impact that amyloid beta (Aβ) accumulation in the brain has on the progression of Parkinson’s disease (PD) pathology is complex and poorly understood…
  • MDS Virtual Congress 2021

    The association of β-amyloid with cognition and striatal dopamine in early, non-demented Parkinson’s disease

    YS. Oh, SW. Yoo, CH. Lyoo, KS. Lee, JS. Kim (Seoul, Republic of Korea)

    Objective: The purpose of this study was to investigate the association among striatal dopaminergic availability, Aβ-positivity, and motor and cognitive status in early and non-demented…
  • MDS Virtual Congress 2021

    Sex differences in brain and cognition in de novo PD patients

    J. Oltra, C. Uribe, A. Campabadal, A. Inguanzo, G. Monté-Rubio, M. Marti, Y. Compta, F. Valldeoriola, C. Junque, B. Segura (Barcelona, Spain)

    Objective: We aimed to investigate sex differences in brain atrophy and cognition in PD de novo patients through MRI subcortical volumetry and cortical thickness (CTh).…
  • MDS Virtual Congress 2021

    DAT-SPECT in old onset Parkinson’s disease: should we trust?

    G. Palermo, S. Giannoni, D. Frosini, U. Bonuccelli, R. Ceravolo (Pisa, Italy)

    Objective: . Background: Scans without evidence of dopaminergic deficit (SWEDD) refers to patients clinically diagnosed with Parkinson’s disease (PD), but show normal findings on dopamine…
  • MDS Virtual Congress 2021

    Developing 31-phosphorus magnetic resonance spectroscopy (31P-MRS) as an imaging biomarker to identify mitochondrial dysfunction in Parkinson’s disease

    T. Payne, M. Sassani, S. Roscoe, S. Bradley, A. Anton, E. Reed, I. Wilkinson, H. Mortiboys, T. Jenkins, O. Bandmann (Sheffield, United Kingdom)

    Objective: To determine if 31P-MRS can identify mitochondrial dysfunction in-vivo and if this correlates with in-vitro measures of mitochondrial function obtained from patient derived fibroblasts…
  • MDS Virtual Congress 2021

    Relationship Between Hyposmia and Olfactory Network Connectivity in Patients With Parkinson’s Disease

    L. Pesantez Pacheco, S. Horovitz (Bethesda, USA)

    Objective: To examine resting-state functional Magnetic Resonance Imaging in a group of Parkinson’s Disease patients, used to characterize changes in functional connectivity of the olfactory…
  • MDS Virtual Congress 2021

    Longitudinal structural and functional brain alterations in Parkinson’s disease patients with freezing of gait

    N. Piramide, F. Agosta, E. Sarasso, T. Stojkovic, I. Stankovic, S. Basaia, A. Tomic, V. Markovic, E. Stefanova, V. Kostic, M. Filippi (Milan, Italy)

    Objective: To investigate the cortical/subcortical grey matter (GM) changes and network functional alterations in PD-FoG patients, in PD developing FoG (PD-FoG-converters) and PD not developing…
  • MDS Virtual Congress 2021

    Clinical and transcranial sonography characteristics in benign phenotype of Parkinson’s disease.

    A. Planas-Ballvé, N. Caballol, A. ávila (Barcelona, Spain)

    Objective: To investigate clinical and transcranial B-mode sonography (TCS) characteristics of benign phenotype of Parkinson’s disease (bPD). Background: Parkinson’s disease (PD) progression is heterogeneous. A…
  • MDS Virtual Congress 2021

    Altered functional connectivity of the hippocampus in posterior-cortical subtype of cognitive impairment in Parkinson’s disease

    D. Pourzinal, J. Yang, G. Byrne, J. O'Sullivan, L. Mitchell, K. Mcmahon, D. Copland, N. Dissanayaka (Herston, Australia)

    Objective: We aimed to delineate the dual syndrome subtypes of PD-MCI using a data-driven approach and explore hippocampal functional connectivity of the posterior-cortical syndrome. Background:…
  • MDS Virtual Congress 2021

    Dissociated longitudinal evolution of limbic serotonergic and striatal dopaminergic and serotonergic pathology in apathetic and non-apathetic patients in early Parkinson’s disease

    S. Prange, E. Metereau, H. Klinger, E. Schmitt, E. Lhommée, A. Bichon, D. Le Bars, A. Maillet, P. Pellissier, S. Meoni, E. Broussolle, A. Castrioto, P. Krack, S. Thobois (Bron, France)

    Objective: To investigate the longitudinal changes in striatal and extra-striatal dopaminergic and serotonergic innervation in apathetic and non-apathetic patients during the five years after the…
  • « Previous Page
  • 1
  • …
  • 984
  • 985
  • 986
  • 987
  • 988
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley